"Jamedica" , MB
Okredo company details
Legal status
ActiveCompany ID
305094394VAT code
LT100013223319Incorporation date
26/03/2019Company's manager/representative
ASTA PETKEVIČIENĖ, DirectorShare capital
-Activity
Wholesale of pharmaceutical goodsContacts
Website
-
C
AverageReliability
Number of employees
0* during past year
Average wage
No data available* during past year
Debts
0.00 €* during past year
Turnover
434,386 €Credit report
25
Data sourcesBusiness linkages
2
LinkagesMonitoring
15
Changes during the yearSimilar companies
366
Similar companiesCompany's value
Register and
explore Okredo dataCredit limit
Estimated
"Jamedica" , MB financial ratios
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
282,702 |
- |
-4,602 |
-4,602 |
- |
12.33 |
-1.63 |
6,157 |
107,486 |
13,525 |
100,118 |
2023 |
---|
583,117 |
- |
5,175 |
4,858 |
- |
14.76 |
0.83 |
11,015 |
127,661 |
7,025 |
131,651 |
2024 |
---|
434,386 |
- |
-18,556 |
-18,556 |
- |
13.65 |
-4.27 |
-7,541 |
84,596 |
1,262 |
75,793 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
434,386 €-26 % *
Sales per employee (€)
-Profit before tax (€)
-18,556 €-459 % *
Net Profit (€)
-18,556 €-482 % *
Profit per employee (€)
-Total profitability (%)
13.65 %-7.52 % *
Net profitability (%)
-4.27 %-614.46 % *
Equity (€)
-7,541 €-168 % *
Amounts Payable And Liabilities (€)
84,596 €-34 % *
Non-current Assets (€)
1,262 €-82 % *
CurrentAssets (€)
75,793 €-42 % *
Credit history
No. of unpaid debts
Register and
explore Okredo dataAmount of unpaid debts
Register and
explore Okredo dataCredit report
Premium users: 1.00 credit
Creditor/Data source | Debt amount | Debt date | Debt type |
---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date / Payment date | Debt type |
---|---|---|---|
- | - | - | - |
Courts
Defendant
(0)
Plaintiff
(0)
3rd party
(0)
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
---|---|---|---|---|---|
- | - | - | - | - | - |
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
---|---|---|---|---|---|
- | - | - | - | - | - |
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
---|---|---|---|---|---|
- | - | - | - | - | - |
ESG data
Energy performance of the company's head office building
Energy efficiency
Vehicles
Company's eco score according CO² of vehicle fleet
Maximum environmental friendliness
Lowest environmental friendliness
Vehicles
CLASS
AMOUNT
Total
1
Eco score | Brand, model | Category | Engine capacity | Fuel |
---|---|---|---|---|
VOLKSWAGEN. VW PASSATFirst registration: 10/06/2016 | Passenger car | 1,968.00 cm³ | Diesel |
Trademarks
Company registered trademarks
No trademarks found
Public data
Govermental support
Institution | Support measure |
---|---|
![]() | Subsidies to preserve work places |
![]() | Subsidies for downtime in 2020 |
![]() | ILTE business promotion measures (subsidies, compensations) in 2020 |
![]() | ILTE business promotion measures (guarantees provided) in 2020 |
![]() | ILTE business promotion measures (guarantees provided) in 2021 |
Register and
explore Okredo dataPublic negative information
Institution | Support measure |
---|---|
![]() | Redundancy of employees group (number of employees notified, date of announcement) |
![]() | Tax inspectorate information on payments in cash |
![]() | Public procurement office information on unreliable suppliers |
![]() | Public procurement office information on those that supplied false data |
![]() | Public procurement office information on possible disqualification from public procurement procedures |
Register and
explore Okredo dataPublic data
Institution | Support measure |
---|---|
![]() | Data from the B2Lithuania database of exporters |
![]() | The biggest taxpayers in 2021 |
![]() | Top taxpayers in 2021 excluding excise duties and VAT. |
![]() | Top personal income tax payers in 2021 |
![]() | Top taxpayers for corporate income tax in 2021 |
Register and
explore Okredo dataLicenses
The company has no records of any licenses', permits, certificates, or other licensing documents issued.
Public procurement
No. of won tenders
94* during past yearTotal value of contracts
896,590 €Number of announced tenders
0* during past yearTotal value of contracts
0 €Date | Procurer/contractor | Amount | Project |
---|---|---|---|
05/06/2025 | Valstybės įmonė Ignalinos atominė elektrinė | 170 € | APSAUGINĖS DARBO PIRŠTINĖS (CPO347198-22967) |
23/05/2025 | Viešoji įstaiga Šilalės rajono savivaldybės sveikatos centras | 135 € | Vienkartinės med. priemonės |
22/05/2025 | Viešoji įstaiga Pasvalio ligoninė | 3,145 € | Vienkartinės medicinos priemonės |
21/05/2025 | Viešoji įstaiga Kėdainių ligoninė | 3,221 € | Vienkartinės medicininės necheminės medžiagos (chirurginės pirštinės) (JAMedica_2025) |
19/05/2025 | Viešoji įstaiga 'Šv. Roko ligoninė' | 10,603 € | Vienkartinės pirštinės |
Date | Procurer/contractor | Amount | Project |
---|---|---|---|
- | - | - | - |
Archive of articles
Similar companies
Description
About "Jamedica" , MB
"Jamedica" , MB was established in 26/03/2019, its legal status according to data of Registry of Legal Entities is Active.Main activity of the company according NACE2 classification – Wholesale of pharmaceutical goods, 46.46.00. Company is owned by 2 shareholders. Company's representation right – Sole representation.
In 2024 "Jamedica" , MB turnover was 434,386 EUR, gross profit -18,556 EUR. According to SODRA company has no employees. "Jamedica" , MB is registered at – Kaunas, Krėvos g. 10-27, LT-44237.
All data about "Jamedica" , MB is up to date and consistent with the primary data source.